We are live on ! Find out more
XC

XY Capital Portfolio holdings

AUM $101M
1-Year Est. Return 1.14%
This Fund
S&P 500
This Quarter Est. Return
+4.8%
1 Year Est. Return
+1.14%
3 Year Est. Return
+44.33%
5 Year Est. Return
10 Year Est. Return
AUM
$224M
AUM Growth
+$52.5M
Cap. Flow
+$39.9M
Cap. Flow %
17.85%
Top 10 Hldgs %
45.06%
Holding
101
New
26
Increased
28
Reduced
29
Closed
17

Top Buys

Rank Stock Value
1
TCOM icon
Trip.com Group
TCOM
+$13.3M
2
YUMC icon
Yum China
YUMC
+$11.5M
3
BHP icon
BHP
BHP
+$6.5M
4
BILI icon
Bilibili
BILI
+$6.21M
5
XYZ
Block Inc
XYZ
+$6.03M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 21.84%
2 Materials 6.09%
3 Technology 5.08%
4 Communication Services 3.65%
5 Healthcare 3.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TQQQ icon
101
ProShares UltraPro QQQ
TQQQ
$32.1B
-8,384
Closed -$213K

Similar funds

XY Capital's Q1 2024 Portfolio in Review

As of Q1 2024, XY Capital held 101 positions worth $224M, up 31% from $171M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

XY Capital deployed $39.9M of net new capital in Q1 2024, opening 26 new positions and adding to 28 existing holdings. Its largest new stake was Yum China: 291,400 shares worth $11.6M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 22% of assets, up from 16% a quarter earlier, followed by Materials and Technology.

On the sell side, the largest reduction was Takeda Pharmaceutical, an estimated $7.89M trimmed.

  • XY Capital's largest Q1 2024 buy was Yum China: 291,400 shares worth $11.6M.
  • XY Capital added most to Trip.com Group in Q1 2024, an estimated $13.3M increase.
  • XY Capital's biggest Q1 2024 reduction was Takeda Pharmaceutical, cutting an estimated $7.89M.
  • XY Capital fully exited ResMed in Q1 2024, selling an estimated $12.8M.
  • XY Capital's ten largest holdings make up 45% of its $224M portfolio in Q1 2024.
  • XY Capital opened 26 new positions and closed 17 in Q1 2024.
  • XY Capital's portfolio value rose 31% quarter-over-quarter to $224M.

Based on XY Capital's 13F filing for Q1 2024, filed 29 Apr 2024.